In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...
In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer ...
The five-year results come from a phase 2b study that tested intismeran autogene in combination with Merck’s Keytruda in ...
News Medical on MSN
A dual-action approach to preventing hepatocellular carcinoma
Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate of recurrence after surgery. Even after complete tumor removal, microscopic ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
For women with a specific type of breast cancer known as HER2-positive (HER2+), any residual (leftover) disease after primary treatment with surgery, chemotherapy, and/or targeted drugs means the risk ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
Beyond broad recommendations for recurrent kidney stone prevention, clinicians and renal dietitians can create personalized plans.
Please provide your email address to receive an email when new articles are posted on . Initiation of prophylactic biologics within 90 days of surgery was linked to reduced risk for recurrence among ...
Please provide your email address to receive an email when new articles are posted on . Delaying initiation of ULT during gout flares had no impact on flare severity, duration or recurrence risk.
Physicians are underestimating the risk for recurrence in more than a third of patients who have undergone resection of a gastrointestinal stromal tumor (GIST). The result is that many patients do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results